Hemolytic disease of the newborn (anti-RhE): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Robot: Changing Category:Disease state to Category:Disease) |
||
Line 22: | Line 22: | ||
{{HDN}} | {{HDN}} | ||
{{SIB}} | {{SIB}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Disease | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Transfusion medicine]] | [[Category:Transfusion medicine]] | ||
Revision as of 20:27, 9 December 2011
Template:DiseaseDisorder infobox
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rhesus blood group system. The anti-RhE antibody can be naturally occurring, or arise following immune sensitization after a blood transfusion or pregnancy.
The anti-RhE antibody is quite common especially in the Rhesus genotype CDe/CDe; it can occasionally cause mild jaundice in the neonate, but it never causes severe haemolytic disease of the newborn. It can occur with other antibodies, usually the anti-Rhc antibody, which can cause a severe hemolytic disease.
References
- Antenatal & neonatal screening (second edition). Chapter 12: Rhesus and other haemolytic diseases, by E.A. Letsky, I. Leck, J.M. Bowman. 2000. Oxford University Press. ISBN 0-19-262827-7.